People | June 04, 2026
Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
Subscribe To Our Newsletter & Stay Updated
